Seroatlas · Human Serome Atlas

LRFN2

Leucine-rich repeat and fibronectin type-III domain-containing protein 2

Also known as: FIGLER2, KIAA1246, LRFN2_HUMAN, SALM1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9ULH4
Gene
LRFN2
Ensembl
ENSG00000156564
Chromosome
6
Canonical length
789 aa
Protein class
Predicted membrane proteins
Subcellular location
Plasma membrane

OverviewNCBI Gene

Predicted to be involved in modulation of chemical synaptic transmission and regulation of postsynapse organization. Predicted to be located in plasma membrane. Predicted to be active in several cellular components, including Schaffer collateral - CA1 synapse; cell surface; and postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2025]

Canonical amino-acid sequenceUniProt

789 residues, UniProt reviewed canonical sequence.

>Q9ULH4|LRFN2
     1  METLLGGLLA FGMAFAVVDA CPKYCVCQNL SESLGTLCPS KGLLFVPPDI DRRTVELRLG
    61  GNFIIHISRQ DFANMTGLVD LTLSRNTISH IQPFSFLDLE SLRSLHLDSN RLPSLGEDTL
   121  RGLVNLQHLI VNNNQLGGIA DEAFEDFLLT LEDLDLSYNN LHGLPWDSVR RMVNLHQLSL
   181  DHNLLDHIAE GTFADLQKLA RLDLTSNRLQ KLPPDPIFAR SQASALTATP FAPPLSFSFG
   241  GNPLHCNCEL LWLRRLERDD DLETCGSPGG LKGRYFWHVR EEEFVCEPPL ITQHTHKLLV
   301  LEGQAATLKC KAIGDPSPLI HWVAPDDRLV GNSSRTAVYD NGTLDIFITT SQDSGAFTCI
   361  AANAAGEATA MVEVSIVQLP HLSNSTSRTA PPKSRLSDIT GSSKTSRGGG GSGGGEPPKS
   421  PPERAVLVSE VTTTSALVKW SVSKSAPRVK MYQLQYNCSD DEVLIYRMIP ASNKAFVVNN
   481  LVSGTGYDLC VLAMWDDTAT TLTATNIVGC AQFFTKADYP QCQSMHSQIL GGTMILVIGG
   541  IIVATLLVFI VILMVRYKVC NHEAPSKMAA AVSNVYSQTN GAQPPPPSSA PAGAPPQGPP
   601  KVVVRNELLD FTASLARASD SSSSSSLGSG EAAGLGRAPW RIPPSAPRPK PSLDRLMGAF
   661  ASLDLKSQRK EELLDSRTPA GRGAGTSARG HHSDREPLLG PPAARARSLL PLPLEGKAKR
   721  SHSFDMGDFA AAAAGGVVPG GYSPPRKVSN IWTKRSLSVN GMLLPFEESD LVGARGTFGS
   781  SEWVMESTV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LRFN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.46
Highest tissue expression
6.3 nTPM

Expression across tissuesHPA

Tissue

  • cerebral cortex: 6.3 nTPM
  • amygdala: 2.9 nTPM
  • retina: 2.9 nTPM
  • hypothalamus: 2.6 nTPM
  • hippocampal formation: 2.4 nTPM
  • cerebellum: 2.3 nTPM

Single-cell type

  • cone photoreceptor cells: 865 nCPM
  • brain excitatory neurons: 97 nCPM
  • rod photoreceptor cells: 91 nCPM
  • oligodendrocyte progenitor cells: 87 nCPM
  • retinal bipolar cells: 79 nCPM
  • brain inhibitory neurons: 71 nCPM

Immune cell

  • gdT-cell: 0.3 nTPM
  • plasmacytoid DC: 0.2 nTPM
  • naive CD4 T-cell: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • cerebral cortex: 41 nTPM
  • white matter: 30 nTPM
  • basal ganglia: 28 nTPM
  • amygdala: 24 nTPM
  • hippocampal formation: 21 nTPM
  • thalamus: 18 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.71
gnomAD pLI
0.01
gnomAD missense Z
1.6
DepMap mean gene effect
0.14
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of LRFN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LRFN2 as an antibody target. Whether an autoantibody or antibody against LRFN2 could matter depends on whether native LRFN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LRFN2 is annotated at the cell surface, where native LRFN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label LRFN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LRFN2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...